Rydar Equities’s Astera Labs ALAB Stock Holding History

Rydar Equities’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$76.4K	Buy	+200	New	+$64.3K	0.04%	156

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

DRP

Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

IFS

Integrated Financial Solutions Reston, Virginia $195M AUM 46.13% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Rydar Equities's ALAB Position: Q3 2026 in Review

Rydar Equities opened a new position in Astera Labs (ALAB) in Q3 2026: 200 shares worth $76.4K. The stake represents 0.04% of the portfolio and ranks #156 among its holdings.

118 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

Rydar Equities held 200 shares of Astera Labs worth $76.4K as of Q3 2026.
Astera Labs was a new Rydar Equities position in Q3 2026.
Astera Labs made up 0.04% of Rydar Equities's portfolio in Q3 2026, its #156 holding.
118 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.